Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.60 EUR
−19.82 M EUR
341.24 M EUR
13.28 M
About POLYPEPTIDE N
Sector
Industry
CEO
Juan-José Gonzalez
Website
Headquarters
Baar
Founded
1952
ISIN
CH1110760852
PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. It operates through the following business areas: Custom Projects, Contract Manufacturing, and Generics and Cosmetics. The Custom Projects business area includes manufacturing of custom research-grade peptides and oligonucleotides for use in pre-clinical and clinical development as well as for regulatory and scientific studies. The Contract Manufacturing business area focuses on peptides for commercial stage peptide therapeutics, at scale, in commercial batches and in accordance with current Good Manufacturing Practice (cGMP) requirements. The Generics and Cosmetics business area is involved in peptide-based generics for the human and veterinary market, produced on an industrial scale following cGMP guidelines. The company was founded in 1952 and is headquartered in Baar, Switzerland.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of 8H0 is 21.10 EUR — it has increased by 0.23% in the past 24 hours. Watch POLYPEPTIDE GROUP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange POLYPEPTIDE GROUP LTD stocks are traded under the ticker 8H0.
8H0 stock has risen by 0.23% compared to the previous week, the month change is a 0.23% rise, over the last year POLYPEPTIDE GROUP LTD has showed a −2.09% decrease.
We've gathered analysts' opinions on POLYPEPTIDE GROUP LTD future price: according to them, 8H0 price has a max estimate of 40.43 EUR and a min estimate of 19.76 EUR. Watch 8H0 chart and read a more detailed POLYPEPTIDE GROUP LTD stock forecast: see what analysts think of POLYPEPTIDE GROUP LTD and suggest that you do with its stocks.
8H0 stock is 3.55% volatile and has beta coefficient of 1.17. Track POLYPEPTIDE GROUP LTD stock price on the chart and check out the list of the most volatile stocks — is POLYPEPTIDE GROUP LTD there?
Today POLYPEPTIDE GROUP LTD has the market capitalization of 709.80 M, it has decreased by −1.21% over the last week.
Yes, you can track POLYPEPTIDE GROUP LTD financials in yearly and quarterly reports right on TradingView.
POLYPEPTIDE GROUP LTD is going to release the next earnings report on Aug 12, 2025. Keep track of upcoming events with our Earnings Calendar.
POLYPEPTIDE GROUP LTD revenue for the last half-year amounts to 201.70 M EUR, despite the estimated figure of 210.20 M EUR. In the next half-year revenue is expected to reach 151.50 M EUR.
8H0 net income for the last half-year is −8.21 M EUR, while the previous report showed −11.37 M EUR of net income which accounts for 27.79% change. Track more POLYPEPTIDE GROUP LTD financial stats to get the full picture.
As of Jun 20, 2025, the company has 1.36 K employees. See our rating of the largest employees — is POLYPEPTIDE GROUP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. POLYPEPTIDE GROUP LTD EBITDA is 23.50 M EUR, and current EBITDA margin is 6.94%. See more stats in POLYPEPTIDE GROUP LTD financial statements.
Like other stocks, 8H0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POLYPEPTIDE GROUP LTD stock right from TradingView charts — choose your broker and connect to your account.